The U.S. Food and Drug Administration’s (FDA) recent approval for Florida to import prescription drugs from Canada marks a significant development in the U.S. prescription drug market. This decision could pave the way for substantial cost savings for Florida, with the state projecting savings of up to $150 million in the first year of the program. The imported medications are expected to treat a range of conditions including HIV, AIDS, prostate cancer, high blood pressure, and mental health disorders. This decision is particularly notable considering the generally higher prices of U.S. drugs compared to those in Canada, with U.S. prices often more than double, and in the case of brand-name drugs, nearly triple those found in Canada. See the drugs that will be allowed for import, the companies that own them, and the active pharmaceutical ingredient they use.
Menu